Authors Review Impact of Calcium Channel Blockers on Antipsychotic-Induced Tardive Dyskinesia
Authors of a review looked to study the impact of calcium channel blocker therapies (diltiazem, nifedipine, nimodipine, verapamil) in treating patients with neuroleptic-induced tardive dyskinesia (TD) and chronic mental illnesses
Clinical Efficacy of the Use or Withdrawal of Anticholinergic Drugs in Tardive Dyskinesia
This study analyzes data regarding the use and withdrawal of anticholinergic drugs (benzhexol, benztropine, biperiden, orphenadrine, procyclidine, scopolamine, or trihexyphenidyl) for the treatment of patients with tardive dyskinesia (TD; among
Insights on Treating Tardive Dyskinesia Using Telehealth
A panel of six neurologists, three psychiatrists, and three psychiatric nurse practitioners participated in a study to outline a framework to address the use of telehealth to treat tardive dyskinesia.
Assessing Minimal Clinically Important Change in Abnormal Involuntary Movement Scale Score in Patients With TD Treated With Deutetrabenazine
Researchers sought to examine the minimal clinically important change (MCIC) in total motor Abnormal Involuntary Movement Scale (AIMS) score in patients with tardive dyskinesia (TD) who were treated with deutetrabenazine.
In a continuing medical education program presented at Psych Congress Regionals 2021, faculty presented on a wide range of topics in tardive dyskinesia (TD). The goals of the presentation were
